...
首页> 外文期刊>European journal of pharmaceutical sciences >Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
【24h】

Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.

机译:基于乙基纤维素和低取代羟丙基纤维素混合物的注塑基质片剂的开发。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The objective of this study was to produce sustained-release matrix tablets by means of injection moulding and to evaluate the influence of matrix composition, process temperature and viscosity grade of ethylcellulose on processability and drug release by means of a statistical design. The matrix tablets were physico-chemically characterized and the drug release mechanism and kinetics were studied. Formulations containing metoprolol tartrate (30%, model drug), ethylcellulose with dibutylsebacate (matrix former and plasticizer) and L-HPC were extruded and subsequently injection moulded into tablets (375mg, 10mm diameter, convex-shaped) at different temperatures (110, 120 and 130 degrees C). Dissolution tests were performed and tablets were characterized by means of DSC, X-ray powder diffraction studies, X-ray tomography, porosity and hardness. Tablets containing 30% metoprolol and 70% ethylcellulose (EC 4cps) showed an incomplete drug release within 24h (<50%). Formulations containing L-HPC and EC in a ratio of 20/50 and 27.5/42.5 resulted in nearly zero-order drug release, while the drug release rate was not constant when 35% L-HPC was included. Processing of these formulations was possible at all temperatures, but at higher processing temperatures the drug release rate decreased and tablet hardness increased. Higher viscosity grades of EC resulted in a faster drug release and a higher tablet hardness. The statistical design confirmed a significant influence of the EC and L-HPC concentration on drug release, while the processing temperature and EC viscosity grade did not affect drug release. Tablet porosity was low (<5%), independent of the formulation and process conditions. DSC and XRD demonstrated the formation of a solid dispersion. The hydration front in the tablets during dissolution was visualized by dynamic X-ray tomography, this technique also revealed an anisotropic pore structure through the tablet.
机译:这项研究的目的是通过注射成型生产缓释基质片剂,并通过统计设计评估基质组成,工艺温度和乙基纤维素的粘度等级对可加工性和药物释放的影响。对基质片剂进行了物理化学表征,并研究了药物释放机理和动力学。挤出含有酒石酸美托洛尔(30%,模型药物),乙基纤维素和癸二酸二丁酯(基质形成剂和增塑剂)和L-HPC的制剂,然后在不同温度(110、120)下注塑成片剂(375mg,直径10mm,凸形)和130摄氏度)。进行了溶出度测试,并通过DSC,X射线粉末衍射研究,X射线断层扫描,孔隙率和硬度对片剂进行了表征。含有30%美托洛尔和70%乙基纤维素(EC 4cps)的片剂在24小时内显示出不完全的药物释放(<50%)。含有比例为20/50和27.5 / 42.5的L-HPC和EC的制剂导致几乎零级药物释放,而当包含35%L-HPC时药物释放速率不是恒定的。这些制剂可以在所有温度下加工,但在更高的加工温度下,药物释放速率降低,片剂硬度提高。较高粘度等级的EC导致更快的药物释放和更高的片剂硬度。统计设计证实了EC和L-HPC浓度对药物释放有显着影响,而加工温度和EC粘度等级则不影响药物释放。片剂的孔隙率低(<5%),与制剂和工艺条件无关。 DSC和XRD证明形成了固体分散体。片剂在溶解过程中的水合前沿通过动态X射线断层显像来观察,该技术还揭示了通过片剂的各向异性孔结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号